For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
FDA Approves First Drug to Treat Agitation Symptoms Associated
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for
First FDA Approved Medication for Agitation Associated with
REXULTI® (brexpiprazole), SZ
Pharma News for Sarepta, Astellas, SiSaf, ImmPACT Bio, Otsuka
REXULTI® (brexpiprazole), MDD
Lundbeck: Alzheimer's agitation drug can make a real difference
Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti
Alzheimer's Disease Insight Report: Current Therapies, Drug
Targets, trials and tribulations in Alzheimer therapeutics
de
por adulto (o preço varia de acordo com o tamanho do grupo)
